FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 64 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,681,000 | +49.0% | 511,799 | +24.3% | 0.00% | 0.0% |
| Q3 2016 | $3,813,000 | +55.9% | 411,727 | +6.9% | 0.00% | 0.0% |
| Q2 2016 | $2,446,000 | -61.8% | 385,144 | -60.8% | 0.00% | 0.0% |
| Q1 2016 | $6,401,000 | -18.5% | 981,815 | +1.4% | 0.00% | -50.0% |
| Q4 2015 | $7,853,000 | +79.5% | 968,305 | +62.2% | 0.00% | +100.0% |
| Q3 2015 | $4,376,000 | -28.0% | 596,994 | +0.7% | 0.00% | 0.0% |
| Q2 2015 | $6,077,000 | +3314.0% | 592,874 | +2978.4% | 0.00% | – |
| Q1 2015 | $178,000 | +223.6% | 19,259 | +147.1% | 0.00% | – |
| Q4 2014 | $55,000 | – | 7,795 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $24,530,000,000 | 3.64% |
| Opaleye Management Inc. | 950,000 | $4,873,000 | 1.39% |
| DSC Advisors, L.P. | 1,187,604 | $6,092,000 | 1.28% |
| DAFNA Capital Management LLC | 335,500 | $1,721,000 | 0.84% |
| Vivo Capital, LLC | 855,000 | $4,386,000 | 0.62% |
| Stonepine Capital Management, LLC | 129,756 | $666,000 | 0.36% |
| Eversept Partners, LP | 107,500 | $551,475 | 0.26% |
| Tekla Capital Management LLC | 930,398 | $4,773,000 | 0.19% |
| Perceptive Advisors | 1,117,324 | $5,732,000 | 0.16% |
| Crestline Management, LP | 217,670 | $1,117,000 | 0.14% |